Kardiovaskular
Step 1
1. Varicose : abnormality dilated vessel with a tortuos source. Usually occurs
in venous system but may also occur in atrial or lymphatic vessel
2. Varicose vein: are enlarged, swollen veins that are caused by faulty valves
in the veins or weak vein walls . It is a sign because the blood flow is
abnormal
3. Tortuous: Twisted veins
4. Vericeal area: area around varicose veins
Step 2
1. Why does woman feel pain and her right leg become swollen and redness?
2. What are the cause of varicose?
Varicose veins are caused by weakened valves and veins in your legs. Normally, one-way valves in
your veins keep blood flowing from your legs up toward your heart. When these valves do not work
as they should, blood collects in your legs, and pressure builds up. The veins become weak, large,
and twisted.
3. What are the risk factors of varicose veins?
hese factors increase your risk of developing varicose veins:
Age. The risk of varicose veins increases with age. Aging causes wear and tear on the
valves in your veins that help regulate blood flow. Eventually, that wear causes the valves to
allow some blood to flow back into your veins where it collects instead of flowing up to your
heart.
Sex. Women are more likely to develop the condition. Hormonal changes during pregnancy,
premenstruation or menopause may be a factor. Female hormones tend to relax vein walls.
Taking hormone replacement therapy or birth control pills may increase your risk of varicose
veins.
Family history. If other family members had varicose veins, there's a greater chance you will
too.
Obesity. Being overweight puts added pressure on your veins.
Standing or sitting for long periods of time. Your blood doesn't flow as well if you're in the
same position for long periods.
Step 3
1. What is the veins anatomy?
Wall: collapse
If there is injury, it will be
More elastic
Muscle pumps
vasodilatation)?
o
Blood volume: when the blood volume is less than normal, to make
it adequate, its needed to be vasoconstriction (body compensation)
Injury
9. Why does woman feel pain and her right leg become swollen and
redness?
Damage of valveblood cant go upwardextravasation swelling and
redness
Sweelingnerves are pressed by the swollen parts.
Varicose veins are caused by weakened valves and veins in your legs. Normally, oneway valves in your veins keep blood flowing from your legs up toward your heart.
When these valves do not work as they should, blood collects in your legs, and
pressure builds up. The veins become weak, large, and twisted.
11. What are the clinical manifestations of varicose veins?
Varicose veins usually don't cause any pain. Signs you may have varicose veins include:
Veins that are dark purple or blue in color
Veins that appear twisted and bulging; often like cords on your legs
When painful signs and symptoms occur, they may include:
An achy or heavy feeling in your legs
Burning, throbbing, muscle cramping and swelling in your lower legs
Worsened pain after sitting or standing for a long time
Itching around one or more of your veins
Skin ulcers near your ankle, which can mean you have a serious form of vascular disease
that requires medical attention
Age. The risk of varicose veins increases with age. Aging causes wear and tear on
the valves in your veins that help regulate blood flow. Eventually, that wear causes the
valves to allow some blood to flow back into your veins where it collects instead of flowing
up to your heart.
-
Sex. Women are more likely to develop the condition. Hormonal changes during
Family history. If other family members had varicose veins, there's a greater chance
Standing or sitting for long periods of time. Your blood doesn't flow as well if you're in
Pelvis
Vagina
Uterus (womb)
Esophagus
Superficial varicosities are the result of high-pressure flow into a normally low-pressure
system. Varicosities carrying retrograde flow are hemodynamically harmful because they
cause recirculation of oxygen-poor, lactate-laden venous blood back into an already
congested extremity. The primary goal of treatment is the ablation of these reflux pathways
with resulting improvement of venous circulation.
In the rare setting of deep system obstruction, varicosities are hemodynamically helpful
because they provide a bypass pathway for venous return. Hemodynamically helpful varices
must not be removed or sclerosed. This condition is encountered rarely, but when it is,
ablation of these varicosities causes rapid onset of pain and swelling of the extremity,
eventually followed by the development of new varicose bypass pathways.
Sclerotherapy, laser and intense-pulsed-light therapy, radiofrequency (RF) or laser ablation,
and ambulatory phlebectomy are the modern techniques used to ablate varicosities.
Numerous reports describe success rates of greater than 90% for less invasive techniques,
which are associated with fewer complications, with comparable efficacy.[4, 5]
Chemical sclerosis or endovenous chemoablation (sclerotherapy) is the most widely
used medical procedure for ablation of varicose veins and spider veins.[6] In this
procedure, a sclerosing substance is injected into the abnormal vessels to produce
endothelial destruction that is followed by formation of a fibrotic cord and eventually by
reabsorption of all vascular tissue layers. For most veins, a detergent sclerosing agent is
agitated with air to create a foam similar to shaving foam. A thorough diagnostic evaluation
is essential prior to treatment. A high degree of technical skill is necessary for effective
sclerotherapy for the following reasons:
Local treatment of the superficial manifestations of venous insufficiency is unsuccessful if
the underlying high points of reflux have not been found and treated. Even when the
patient appears to have only primary telangiectasias and the initial treatment seems to be
successful, recurrences are observed very quickly if unrecognized reflux exists in larger
subsurface vessels.
Missing the diagnosis of superficial truncal incompetence can cause significant
complications (especially skin staining and telangiectatic matting) if spider veins and
superficial tributaries are treated while high-pressure feeders remain open.
Delivery of sclerosant to subsurface feeding vessels that are not visible is usually
performed under ultrasonographic guidance.
Missing the diagnosis of deep system disease can lead to bad outcomes in several ways.
Symptoms become immediately worse if an unrecognized bypass pathway is ablated.
Missing the diagnosis of underlying venous thrombosis can lead to fatal embolism.
Unrecognized deep venous insufficiency can lead to early or immediate recurrence of
treated superficial disease.[7]
Selection of the correct sclerosant and the correct volume and concentration of
sclerosant depends on the type and location of disease, internal volume of the vessel to
be treated, positioning of the patient, and many other factors. The minimum effective
concentration and volume should always be used because sclerosant inevitably passes
into the deep venous system, where endothelial injury can lead to disastrous
consequences.
Some sclerosants (eg, hypertonic sodium chloride solution) are highly caustic.
Extravasation of even a single drop of these agents can lead to skin sloughing and a very
poor cosmetic result.
Inadvertent injection into an arteriovenous malformation (or directly into an unrecognized
underlying artery) can cause extensive tissue loss or loss of the entire limb.
Inadvertent injection of concentrated sclerosants into the deep system can cause deep
vein thrombosis, pulmonary embolism, and death.
The proper use of sclerosing agents requires special training and extended study. Specific
dosing and technique recommendations for the administration of sclerosants are beyond the
scope of this article.
The most commonly used sclerosants today are polidocanol and sodium tetradecyl
sulfate, both known as detergent sclerosants because they are amphiphilic substances
that are inactive in dilute solution but are biologically active when they form micelles.
These agents are preferred because they have a low incidence of allergic reactions,
produce a low incidence of staining and other cutaneous adverse effects, and are
relatively forgiving if extravasated.[8] These are best delivered as a foam, which is made
by agitating the solutions with air to create a frothy substance.
Sodium morrhuate is an older detergent sclerosant that is made up of a mixture of
saturated and unsaturated fatty acids extracted from cod liver oil. The agent is of variable
composition and has been associated with a relatively high incidence of anaphylaxis. The
incidence of extravasation necrosis is high with this drug.
Ethanolamine oleate, a synthetic preparation of oleic acid and ethanolamine, has weak
detergent properties because its attenuated hydrophobic chain lengths make it
excessively soluble and decrease its ability to denature cell surface proteins. High
concentrations of the drug are necessary for effective sclerosis. Allergic reactions are
uncommon, but reports exist of pneumonitis, pleural effusions, and other pulmonary
symptoms following the injection of ethanolamine oleate into esophageal varices. The
principal disadvantages of the drug are a high viscosity that makes injection difficult, a
tendency to cause red cell hemolysis and hemoglobinuria, the occasional production of
renal failure at high doses, the possibility of pulmonary complications, and a relative lack
of strength compared with other available sclerosants.
Hypertonic sodium chloride solution in a 20% or 23.4% solution can be used as a
sclerosing agent. The principal advantage of the agent is the fact that it is a naturally
occurring bodily substance with no molecular toxicity, but the disadvantages of the agent
make it unsuitable except in the hands of highly skilled practitioners.
Because of dilutional effects, achieving adequate sclerosis of large vessels without
exceeding a tolerable salt load is difficult.
It can cause significant pain on injection and significant cramping after a treatment
session.
If extravasated, it almost invariably causes significant necrosis. Seeing patients with
dozens of disfiguring scars at the sites of extravasation of hypertonic sodium chloride
solution is not uncommon.
Because it causes immediate red blood cell hemolysis and rapidly disrupts vascular
endothelial continuity, it may cause marked hemosiderin staining that is not cosmetically
acceptable.
Food and Drug Administration (FDA) approval of drug labeling is an important concern for
physicians and patients in the United States. Polidocanol is the most widely used
sclerosant in the world, but the agent has not been approved by the FDA. Sotradecol,
sodium morrhuate, and ethanolamine oleate all were developed prior to the establishment
of the FDA. These agents are available in the United States as grandfathered agents. The
newest form of Sotradecol was cleared by the FDA in 2006. It is highly purified with no
contaminants.
The safety of sclerosing agents in pregnancy has not been established.
Transcutaneous pulsed dye laser and intense-pulsed-light (IPL) therapy has proven
effective for the tiniest surface vessels (eg, those found on the face), but this modality is not
generally useful as primary therapy for treatment of spider veins of the lower extremity. This
is true for several reasons.
Because of the physics of light absorption, delivering an ablative dose of thermal energy
to the vessel without damaging the overlying skin is difficult.
The degree of patient-to-patient variability of light absorption in the skin is high. Even an
experienced practitioner may inadvertently cause painful skin burns that can lead to
permanent hyperpigmentation or hypopigmentation.
For most patients, the laser pulses are significantly more painful than the 30-gauge
needles used for microsclerotherapy.
Most spider veins have associated feeding vessels that must be treated by some other
means before the tiny surface vessels are amenable to laser or IPL treatment.
Dudelzak et al report successful treatment of facial spider veins (telangiectasias) with a
980-nm diode laser. No complications were reported.
varicose veins?
Step 4
Veins
Risk factor
Elasticity
Damage valves
varicose
diagnosis therapy